About this trial
Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.
Eligibility criteria
Qualifiers
Primary diagnosis of BPH with LUTS with prescribed medical treatment or surgical intervention
Disqualifiers
Non-symptomatic BPH
No treatment prescribed for BPH
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
26Sponsors and collaborators
Société Internationale d'Urologie
Lead sponsor